Trampitsch E, Oher M, Pointner I, Likar R, Jost R, Schalk H V
Abt. für Anästhesie und Allgemeine Intensivmedizin, Landeskrankenhaus, St. Veiter Strasse 47, 9020 Klagenfurt, Austria.
Anaesthesist. 2006 Nov;55(11):1166-8. doi: 10.1007/s00101-006-1085-5.
The propofol infusion syndrome is a rare but potentially lethal complication resulting from a prolonged continuous administration of propofol. It was first described in the beginning of the 1990's and in recent years there have been frequent reports of problems in association with the use of propofol sedation. The cardinal signs and symptoms of the propofol infusion syndrome are metabolic acidosis, rhabdomyolysis, renal failure, cardiac arrhythmias and a progressive, often therapy-resistant cardiac failure. The pathophysiology of this syndrome appears to involve a disturbance of mitochondrial metabolism induced by propofol. Our report involves a case of propofol infusion syndrome in a patient having undergone cardiac surgery.
丙泊酚输注综合征是一种罕见但可能致命的并发症,由长时间持续输注丙泊酚引起。它于20世纪90年代初首次被描述,近年来,与丙泊酚镇静使用相关的问题报道频繁。丙泊酚输注综合征的主要体征和症状是代谢性酸中毒、横纹肌溶解、肾衰竭、心律失常以及进行性、通常对治疗有抵抗性的心力衰竭。该综合征的病理生理学似乎涉及丙泊酚引起的线粒体代谢紊乱。我们的报告涉及一例心脏手术后发生丙泊酚输注综合征的病例。